Personalized medicine

The company’s platform, OncoGaze, analyzes genomic biomarkers from routine clinical slides to help clinicians select personalized therapies.

According to CMS' Amy Gleason, the agency is inspiring innovation by offering vendors the opportunity to develop secure, CARIN code-certified patient-facing apps. These apps will be made available via the Medicare.gov website.

General Catalyst's Dr. Stephen Klasko says he's launched a medical education program that integrates AI and data literacy and chooses students based on communication skills, empathy and cultural competence rather than test scores.

Mount Sinai Health System, Nvidia and ARC Innovation Center leaders describe how their collaboration aims to decode the human genome using AI in order to more precisely predict disease risk and understand individual therapy response.

Dr. Amit Zabtani, an orthopedic surgeon at UCLA and cofounder and CMO of CustoMED, says the company uses 3D printing to create patient-specific instruments based on an individual’s anatomy, enabling more precise positioning during surgery.

Sergio Calvo, general manager of theranostics at GE HealthCare, discusses the organization's use of theranostics in cancer care and how the technology combines targeted therapy with diagnostic imaging for personalized oncology care.

Despite tightening barriers to entry over the years, Europe and the US are still key to global expansion for Korean startups, says Sky Labs CEO Jack Byunghwan Lee.

Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.

The partners are employing AI to identify undiagnosed and undertreated patients, support clinical trials and advance precision therapies.